000 01340 a2200385 4500
005 20250517170651.0
264 0 _c20180725
008 201807s 0 0 eng d
022 _a1095-9327
024 7 _a10.1016/j.mcn.2017.08.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcDowall, Jennifer S
245 0 0 _aAlpha-synuclein ferrireductase activity is detectible in vivo, is altered in Parkinson's disease and increases the neurotoxicity of DOPAL.
_h[electronic resource]
260 _bMolecular and cellular neurosciences
_c12 2017
300 _a1-11 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aBrain
_xmetabolism
650 0 4 _aFMN Reductase
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aParkinson Disease
_xmetabolism
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aalpha-Synuclein
_xmetabolism
700 1 _aNtai, Ioanna
700 1 _aHoneychurch, Kevin C
700 1 _aHart, John P
700 1 _aColin, Philippe
700 1 _aSchneider, Bernard L
700 1 _aBrown, David R
773 0 _tMolecular and cellular neurosciences
_gvol. 85
_gp. 1-11
856 4 0 _uhttps://doi.org/10.1016/j.mcn.2017.08.001
_zAvailable from publisher's website
999 _c27468617
_d27468617